Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Short-Term Debt issuances (2016 - 2023)

China Pharma Holdings' Short-Term Debt issuances history spans 4 years, with the latest figure at $1.0 million for Q4 2023.

  • For Q4 2023, Short-Term Debt issuances changed N/A year-over-year to $1.0 million; the TTM value through Dec 2024 reached $1.0 million, down 32.96%, while the annual FY2025 figure was $699996.0, 42.06% up from the prior year.
  • Short-Term Debt issuances reached $1.0 million in Q4 2023 per CPHI's latest filing, up from -$6171.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $3.0 million in Q3 2021 to a low of -$6171.0 in Q3 2023.
  • Average Short-Term Debt issuances over 3 years is $690606.6, with a median of $336052.0 recorded in 2020.
  • The largest YoY upside for Short-Term Debt issuances was 292.66% in 2021 against a maximum downside of 92.68% in 2021.
  • A 3-year view of Short-Term Debt issuances shows it stood at $160979.0 in 2020, then plummeted by 92.68% to $11790.0 in 2021, then soared by 8667.42% to $1.0 million in 2023.
  • Per Business Quant, the three most recent readings for CPHI's Short-Term Debt issuances are $1.0 million (Q4 2023), -$6171.0 (Q3 2023), and -$6011.0 (Q2 2023).